Yes, administering shockwave therapy to patients professionally requires a license — specifically a state-issued healthcare license such as physical therapist, chiropractor, or physician, depending on jurisdiction. Personal at-home use on your own body operates under a different standard and does not require licensure.

Shockwave therapy is classified as a medical procedure when delivered by a practitioner to a patient in a clinical setting, which means it falls under state practice acts governing physical therapists, chiropractors, and sports medicine physicians. The rules vary by state — some allow licensed massage therapists or athletic trainers to operate ESWT devices under supervision, others do not. At-home radial ESWT devices like the Kalecope Q60 are designed for personal self-use, which sidesteps the practitioner licensing question entirely.

  • Clinical shockwave therapy requires a state healthcare license; specific license type (PT, DC, MD) varies by state.
  • The FDA cleared radial ESWT for plantar fasciitis in 2000; cleared devices can legally be sold for personal home use without a prescription in the US.
  • At-home radial devices like the Kalecope Q60 (up to 8 bar) are classified for personal use — no practitioner license required for self-treatment.
  • Some states permit licensed massage therapists or athletic trainers to operate ESWT devices only under direct physician or PT supervision.
  • Focused shockwave therapy, used for deeper or bone-adjacent conditions, is restricted to licensed clinical settings in all US jurisdictions.

Safety Notes

  • Never treat another person with your home device: Using a personal-use ESWT device like the Kalecope Q60 on another individual crosses into unlicensed practice territory in most states.
  • Avoid treatment over active infections, tumors, or blood clots: Shockwave pressure waves accelerate circulation in the treatment area — applying them over pathological tissue can spread the condition.
  • Do not use over growth plates in minors: Radial ESWT applied near open growth plates carries a real injury risk; the Kalecope Q60 is designed for adult self-use only.
  • Skip treatment over implanted devices or metal hardware: Pressure waves transmit through tissue unpredictably around implanted pacemakers, nerve stimulators, or surgical hardware near the treatment site.
  • Do not treat acutely inflamed tissue in the first 48 hours of injury: Applying shockwave to a fresh acute injury can intensify inflammation before the tissue is ready for mechanical stimulus.